NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=150665&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=150719&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

There are only 2 ETF options to invest in the BDC segment, and BIZD is one of them. Even though it is the largest and most liquid alternative, it has some notable drawbacks. In this article, I elaborate in more detail on why BIZD is, in my view, a suboptimal choice for investors, who want to go long the BDC land.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=150666&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

SYDNEY--(BUSINESS WIRE)--JFrog Ltd. (“JFrog”) (NASDAQ: FROG), the Liquid Software company and creators of the award-winning JFrog Software Supply Chain Platform, today announced Sunny Rao has joined the company as Senior Vice President (SVP) of Asia Pacific (APAC) sales. Reporting directly to JFrog's Chief Revenue Officer (CRO), Tali Notman, Rao will spearhead the company's growth initiatives across APAC, helping customers achieve their business transformation goals utilizing the JFrog Platform.

Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical product candidates Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical product candidates

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150667&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.

SentinelOne Inc S reported better-than-expected sales for the first quarter after the market close on Wednesday.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SentinelOne announced that it has been named a Customers' Choice in the 2025 Gartner® Peer Insights™ ‘Voice of the Customer' for XDR report.

ST. PETERSBURG, Fla. , May 29, 2025 /PRNewswire/ -- Webull Corporation (Nasdaq: BULL) ("Webull" or the "Company"), the owner of the Webull online investment platform, announced today that it has delivered a notice of redemption to redeem on June 30, 2025 (the "Redemption Date") all of its outstanding incentive warrants (the "Incentive Warrants"; Nasdaq: BULLZ), which are exercisable for the Company's Class A ordinary shares, par value $0.00001 per share (the "Class A Ordinary Shares") at an exercise price of $10.00 per share and which were issued in connection with the closing of the Company's business combination under the Warrant …

TLT's recent sharp selloff has priced in some fiscal deficit concerns, with 2-20 yield spread widening to 100 bps, indicating the current yield has embedded higher term premium. TLT has reached a 5% yield, surpassing the S&P 500's 4.7% earnings yield due to the recent V-shaped rebound in the equity market, as the market priced out recession risk in 2025. With yields nearing the 5.25%–5.5% resistance range, dip buyers may step in as cooling inflation makes further Fed hikes unlikely.

HIAWATHA, Iowa--(BUSINESS WIRE)-- #AmazonSignageStick--Arreya & Amazon Signage Stick: Powerful digital signage, now amazingly simple! Launch vibrant displays in minutes. 30-day free trial.

PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO) on behalf of purchasers of Open Lending securities between February 24, 2022 through March 31, 2025, inclusive (the “Class Period”).

Michelle Jou, CEO of bp Castrol, says that relying on air cooling for data centers is "unsustainable", and that she is confident that the transition towards immersion cooling technologies will happen as it is the most efficient solution when it comes to a server's thermal efficiency, safety, and life-cycle management.

Meta Platform's AI push will be a key driver for the company in 2025, with integrations coming across numerous platforms, which is fueling engagement and increasing ad sales.

Best Buy (BBY) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.20 per share a year ago.

Spartan Stores (SPTN) came out with quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.53 per share a year ago.

Kohl's (KSS) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.24 per share a year ago.

After Tennant figured out how to keep its plants open during the pandemic, it had a second problem to solve.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=150670&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.